Skip to content
Recall Observatory FDA recall evidence

Drug product

Verapamil Hydrochloride Injection, USP 5 mg / 2mL(2.5 mg/mL), packaged as (a) 25x2 mL Single-Dose Vial per carton, Vial NDC: 70710-1643-1; Carton NDC 70710-1643-7; (b) 5x2 mL Single-Dose Vial per carton, Vial NDC: 70710-1643-1; Carton NDC 70710-1643-5; Rx Only, Manufactured by: Zydus Lifesciences Ltd. Vadodara, India, Distributed by: Zydus Pharmaceuticals (USA)Inc., Pennington, NJ 08534,

D-0592-2024

July 02, 2024

Class III

Product summary

Firm
Zydus Pharmaceuticals (USA) Inc
Event
Event 94912
Status
Ongoing
Classification
Class III
Quantity
170,755 vials
Official record key
drug-enforcement:D-0592-2024

Official wording

Reason: Cross contamination with other products.

Code information: Lot# (a) Lots L300255, L300262, Exp Date 07/31/2025; (b)L300263, Exp Date 08/31/2025

Distribution pattern: Nationwide in the USA

Derived failure modes

  • Unknown

    reason.no_named_rule · v1.0.0

    Cross contamination with other products.